- Home
- Applications
- disease diagnosis
Refine by
Disease Diagnosis Product Applications
9 applications found
Patients, practitioners, researchers and you – the payer, all benefit from earlier, more accurate central nervous system disease diagnosis and monitoring of patients throughout the care continuum. ...
ByQynapse based in Paris, FRANCE
Prostate cancer is the fourth most common cancer diagnosis in worldwide, with 1 300 000 new cases and 360 000 deaths in 2018 (Globocan 2018). At the initial diagnosis the disease, more than 60% of cases are diagnosed as localized prostate cancer. ...
ByOncoDiag based in Miserey, FRANCE
BladderView M5 is not just a bladder scanner. It provides an additional function to measure bladder wall thickness. Such integration makes it a powerful tool to improve clinical efficiency. ...
BySuzhou PeakSonic Medical Technology Co.,Ltd based in Kunshan, Suzhou, CHINA
Automated MRI analyses that may help inform earlier, more accurate viewsof CNS disease, such as Alzheimer’s, Parkinson’s and multiple sclerosis. For healthcare providers on the frontlines of diagnosing and treating central nervous system disease, and for your patients, Qynapse brings groundbreaking peace of mind by providing results you can trust through its flagship solution, QyScore. ...
ByQynapse based in Paris, FRANCE
Alzheimer’s disease is a major cause of severe cognitive decline in the aged. The primary cognitive deficiencies are revealed in working memory, language, executive functions, attention, and long-term ...
ByBrainsWay Ltd. based in Burlington, MASSACHUSETTS (USA)
Clinical diagnostics as e.g. measurement of bacteria in urine with a luciferase based assay of bacterial ATP can be used in the diagnosis of urinary tract infection (UTI). Screening for Duchenne’s Muscular Dystrophy (DMD) has been performed in 528,410 newborn boys in a German study. Luciferase based assays of ATP and ATP+AMP is more and more used to control hospital hygiene. Please have a look at the application listing below to navigate to the product that matches your need. ...
ByBioThema AB based in Handen, SWEDEN
Rapid and efficient screening tools are an essential step in the global fight against COVID-19 and key to ensuring a safe return to daily life and social interactions. Today, nucleotide-based testing (RT-PCR) is the gold standard for diagnosing the disease. But, while sensitive, these tests are limited by long turnaround times, high costs and a typically invasive and uncomfortable nature of ...
ByAbionic SA based in Epalinges, SWITZERLAND
In the development of new drugs high throughput screening (HTS) is often used to screen large libraries of compounds for inhibitors or stimulators of various reactions. The firefly luciferase reaction can be performed reliably in a small reaction volume and is therefore highly suitable for HTS. Our Protein Kinase Kit RR can be used to measure not only protein kinase, but also all ATPases and aminoacyl tRNA synthetases. Growth inhibition from e.g. antibiotics can be measured. Gene expression can be monitored. ...
ByBioThema AB based in Handen, SWEDEN
Many genetic lung diseases have associated complications involving other organs that, if detected early, can be treated effectively. Early diagnosis is important for preserving lung function. Once a diagnosis of any type of rare lung disease is confirmed, patients will be closely monitored for the development of complications, including lung infection, pneumothorax (collapsed lung), or end-stage lung disease. Earlier ...
ByTesis Biosciences based in Scottsdale, ARIZONA (USA)